Dr. Bottini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1255 Friendship Rd
Ste 160
Braselton, GA 30517Phone+1 678-528-1101Fax+1 678-528-3254
Education & Training
The Retina InstituteFellowship, Surgical Retina and Vitreous, 2019 - 2021
NYU Grossman School of MedicineResidency, Ophthalmology, 2016 - 2019
Emory University School of MedicineInternship, Transitional Year, 2015 - 2016- Emory University School of MedicineClass of 2015
Certifications & Licensure
GA State Medical License 2021 - 2026
IL State Medical License 2019 - 2023
MO State Medical License 2019 - 2023- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 21 citationsInitial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration.Ella H Leung, Daniel J Oh, Shannon E Alderson, Joshlynn Bracy, Mia McLeod
Clinical Ophthalmology. 2023-01-01 - 13 citationsPurtscher-Like Retinopathy in a Patient with COVID-19Alexander R. Bottini, Sean Steinmetz, Kevin J. Blinder, Gaurav K. Shah
Case Reports in Ophthalmological Medicine. 2021-03-20 - Long-Term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization.Alexander R Bottini, Barton L Blackorby, Madelyn Michaels, Katherine Burkett, Sabin Dang
Journal of Vitreoretinal Diseases. 2020-06-17
Journal Articles
- Long-Term Outcomes in Macular Telangiectasia Type 2 with Subretinal NeovascularizationBottini AR, Blackorby BL, Michaels M, Burkett K, Dang S, Blinder KJ, Shah GK, Journal of VitreoRetinal Diseases, 6/17/2020
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
